US Patent 11338117 Implantable dual pathway therapeutic agent delivery port
Patent 11338117 was granted and assigned to TriSalus Life Sciences on May, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11338117 Implantable dual pathway therapeutic agent delivery port
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
